WUXITECAN-2
LIVE

Serial Number

99726259

Owner

WuXi XDC Cayman Inc.

Attorney

Candice Reder

Filing Date

Mar 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

WUXITECAN-2 Trademark

Serial Number: 99726259

WUXITECAN-2 is a trademark filed by WuXi XDC Cayman Inc. on March 26, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

WuXi XDC Cayman Inc. (15 trademarks)

No.11, Xinhui Ring Road
Wuxi, Jiangsu Province 214028 , CN

Entity Type: 03

Trademark Details

Filing Date

March 26, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for inhibiting tumors; Pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Antibodies for medical purposes; Biologics in the nature of cells for the treatment of cancer

Custom manufacture of pharmaceuticals; Custom manufacturing of pharmaceuticals; Manufacturing services for others in the field of antibody drug conjugates and intermediates thereof; Custom manufacture of pharmaceutical preparations, biomedical preparations, drug conjugates, anti-body drug conjugates, chemical reagents; Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process

Active chemical ingredients for use in the manufacture of pharmaceuticals; Chemical reagents, other than for medical or veterinary purpose; Biochemical catalysts; Biological preparations for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Heterocyclic compounds; Chemical preparations for use in the manufacture of pharmaceuticals; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new pharmaceutical development

Filing History

APPLICATION FILING RECEIPT MAILED
Mar 26, 2026 MAFR
NEW APPLICATION ENTERED
Mar 26, 2026 NWAP